Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy

The evidence for DPP-4 inhibitors effectiveness at the late stages of type 2 diabetes mellitus (T2DM) are still growing. This is particularly important for those patients who receive insulin without adequately glycemic control. This publication provides the overview of studies which demonstrate high...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gagik Radikovich Galstyan, Svetlana Viktorovna Sergeeva
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2015
Sujets:
Accès en ligne:https://doaj.org/article/d475d6cca7794363a7a0ff5051ec970b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!